All News
Filter News
Found 174 articles
-
Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting
6/13/2023
Bionano Genomics, Inc. announced its participation in the International Society for Stem Cell Research Annual Meeting 2023 with a broad range of content covering the utility of optical genome mapping for research, development, and manufacturing applications in stem cell therapy.
-
Bionano Announces 2023 Winners of its Innovator Research Grant Program
6/12/2023
Bionano Genomics, Inc. announced the 2023 winners of its Innovator Research Grant program, including grand prize winner Dr. Michael Khodadoust at Stanford University.
-
Bionano Announces Extensive Lineup of Content at European Conferences Featuring OGM Utility Across a Broad Range of Research Applications
6/8/2023
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the company’s robust presence at key European cytogenetic conferences, including the European Hematology Association (EHA) 2023 Congress, the European Human Genetics (ESHG) 2023 Conference and the European Association for Cancer Research (EACR) 2023 Congress.
-
Bionano Announces Commercial Release of New Kits for its Ionic System featuring New Chemistry for Nucleic Acid Extraction from FFPE and Tumor Tissue
6/6/2023
Bionano Genomics, Inc. announced the commercial release of new kits for its Ionic® Purification System featuring new chemistry for nucleic acid extraction from formalin-fixed paraffin-embedded and tumor tissue.
-
Colossal Biosciences and the Vertebrate Genomes Project Publish the First Near Complete African Elephant Chromosome Level Genome
5/18/2023
Colossal Biosciences, a breakthrough biosciences and genetic engineering company, and the Vertebrate Genomes Project, which aims to sequence high-quality reference genomes for all living vertebrates, partnered to successfully generate the first high-quality reference genome of the African elephant.
-
Bionano to Report First Quarter 2023 Financial Results and Host a Conference Call and Webcast on May 9, 2023
5/2/2023
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, May 9, 2023, at 4:30 p.m. Eastern Time to report financial results for the first quarter 2023 and to highlight recent corporate progress.
-
Research Shows Long Read Sequencing Market is Rising at 22.3% CAGR by 2028
4/18/2023
The Insight Partners published latest research report on "Long Read Sequencing Market Trends Report, Size, Share, Growth Rate Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology, Product, Application, End User and Geography,"
-
Sengenics Corporation Announces Yvonne Linney, PhD as New Board Director
1/9/2023
Sengenics Corporation LLC, driving the discovery of next-gen biomarkers through its immuno-proteomic platform, KREX®, and Summa Equity announce that Yvonne Linney PhD. has been appointed to the company’s Board of Directors, effective immediately.
-
Ionpath Names Goran Pljevaljcic as Chief Commercial Officer
11/1/2022
Ionpath, a pioneer in high-definition spatial proteomics, announced today that Goran Pljevaljcic has joined the company as its Chief Commercial Officer.
-
Next-Generation Sequencing Data Analysis Market Size USD 2.4 BN by 2030 With a CAGR of 13.9%
10/27/2022
Latest Study on “Next-Generation Sequencing Data Analysis Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030”.
-
Gene Panel Market Size, Share, Growth, Trends | Report 2022-2030
10/4/2022
According to Vision Research Reports, the global gene panel market was surpassed at USD 750.8 million in 2021 and is expected to hit around USD 2.97 billion by 2030, growing at a CAGR of 16.51% from 2022 to 2030.
-
Introducing Cantata Bio, Inventive Multimodal Solutions for Accelerating Genome-based R&D
6/6/2022
Introducing Cantata Bio, Inventive Multimodal Solutions for Accelerating Genome-based R&D.
-
Singular Genomics Announces Formation of Scientific Advisory Board
5/10/2022
Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the formation of its scientific advisory board (SAB).
-
TwinStrand Biosciences Expands Executive Team With Appointment of Goran Pljevaljcic as Chief Commercial Officer
4/28/2022
TwinStrand Biosciences, Inc. today announced the appointment of Goran Pljevaljcic, Ph.D. as Chief Commercial Officer.
-
Long Read Sequencing Market Growth – at a CAGR of 21.1% During Forecast Period 2020-2028
4/12/2022
Increasing prevalence of infectious diseases and genetic disorders across the globe, rapid advancements in genomic sequencing techniques, and rising number of genomic research based activities are some key factors expected to drive global market growth.
-
Long-Read Sequencing Market Size to Reach USD 2,313.8 Million in 2028
4/4/2022
Rising Number of Genetic Disorders and Population Genomics is Driving Industry Demand, Says Emergen Research
-
BioSpace Movers & Shakers, Feb. 18
2/18/2022
Biopharma and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers. -
Clinical Catch-Up: January 10-14
1/17/2022
Heading into the middle of January, companies announced plenty of new clinical trial news. Here’s a look. -
Inhibrx Strengthens Leadership Team with Three Key Executive Hires and Announces Appointment of Kristiina Vuori, M.D., Ph.D. to its Board of Directors
10/28/2021
Inhibrx, Inc. (Nasdaq: INBX), announced the appointment of three key executives: David Matly, M.B.A., as Chief Commercial Officer; David Kao, PharmD, M.B.A., RPh, as Vice President of Regulatory Affairs; and Jack Tsai, M.D., M.B.A., as Vice President of Business Development.
-
Gene Panel Market is anticipated to grow with the increasing number of incidents of product launches | TMR Research Study
9/2/2021
There is a rapid increase in chronic diseases that are closely associated with human genes. Such diseases in the line include arthritis, cancer, heart attack, stroke, and some other relative illnesses.